Related references
Note: Only part of the references are listed.N-(4-Substituted-benzoyl)-N′-(β-D-glucopyranosyl)ureas as inhibitors of glycogen phosphorylase: Synthesis and evaluation by kinetic, crystallographic, and molecular modelling methods
Veronika Nagy et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2012)
mTOR Signaling in Growth Control and Disease
Mathieu Laplante et al.
CELL (2012)
Glucose Utilization via Glycogen Phosphorylase Sustains Proliferation and Prevents Premature Senescence in Cancer Cells
Elena Favaro et al.
CELL METABOLISM (2012)
Hepatic mTORC2 Activates Glycolysis and Lipogenesis through Akt, Glucokinase, and SREBP1c
Asami Hagiwara et al.
CELL METABOLISM (2012)
Acetylation Negatively Regulates Glycogen Phosphorylase by Recruiting Protein Phosphatase 1
Tengfei Zhang et al.
CELL METABOLISM (2012)
The Prototype of Glycogen Phosphorylase
E. D.Chrysina
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2012)
Poly(ADP-ribose) polymerase-2 depletion reduces doxorubicin-induced damage through SIRT1 induction
Magdolna Szanto et al.
CARDIOVASCULAR RESEARCH (2011)
PARP-2 Regulates SIRT1 Expression and Whole-Body Energy Expenditure
Peter Bai et al.
CELL METABOLISM (2011)
PARP-1 Inhibition Increases Mitochondrial Metabolism through SIRT1 Activation
Peter Bai et al.
CELL METABOLISM (2011)
Glucose derived inhibitors of glycogen phosphorylase
Laszlo Somsak
COMPTES RENDUS CHIMIE (2011)
mTOR: from growth signal integration to cancer, diabetes and ageing
Roberto Zoncu et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2011)
Molecular basis for the differential use of glucose and glutamine in cell proliferation as revealed by synchronized HeLa cells
Sergio L. Colombo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Genetic Ablation of PARP-1 Protects Against Oxazolone-Induced Contact Hypersensitivity by Modulating Oxidative Stress
Attila Brunyanszki et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2010)
Physiological Control of Liver Glycogen Metabolism: Lessons from Novel Glycogen Phosphorylase Inhibitors
L. Agius
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2010)
Prolonged Inhibition of Glycogen Phosphorylase in Livers of Zucker Diabetic Fatty Rats Models Human Glycogen Storage Diseases
Eike Floettmann et al.
TOXICOLOGIC PATHOLOGY (2010)
Disruption of the allosteric phosphorylase a regulation of the hepatic glycogen-targeted protein phosphatase 1 improves glucose tolerance in vivo
Ian R. Kelsall et al.
CELLULAR SIGNALLING (2009)
Assessment of synthetic methods for the preparation of N-β-D-glucopyranosyl-N′- substituted ureas, -thioureas and related compounds
Laszlo Somsak et al.
CARBOHYDRATE RESEARCH (2008)
New Inhibitors of Glycogen Phosphorylase as Potential Antidiabetic Agents
L. Somsak et al.
CURRENT MEDICINAL CHEMISTRY (2008)
New hepatic targets for glycaemic control in diabetes
Loranne Agius
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKCα but not S6K1
David A. Guertin et al.
DEVELOPMENTAL CELL (2006)
Bioenergetics and the formation of mitochondrial reactive oxygen species
Vera Adam-Vizi et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2006)
Critical nodes in signalling pathways: insights into insulin action
CM Taniguchi et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)
Lack of UCP2 reduces fas-mediated liver injury in ob/ob mice and reveals importance of cell-specific UCP2 expression
Peter Fulop et al.
HEPATOLOGY (2006)
The experimental type 2 diabetes therapy glycogen phosphorylase inhibition can impair aerobic muscle function during prolonged contraction
David J. Baker et al.
DIABETES (2006)
Glycogen phosphorylase inhibition in type 2 diabetes therapy - A systematic evaluation of metabolic and functional effects in rat skeletal muscle
DJ Baker et al.
DIABETES (2005)
FR258900, a novel glycogen phosphorylase inhibitor isolated from Fungus No. 138354 - II. Anti-hyperglycemic effects in diabetic animal models
S Furukawa et al.
JOURNAL OF ANTIBIOTICS (2005)
Kinetic and crystallographic studies on 2-(β-D-glucopyranosyl)-5-methyl-1,3,4-oxadiazole, -benzothiazole, and -benzimidazole, inhibitors of muscle glycogen phosphorylase b.: Evidence for a new binding site
ED Chrysina et al.
PROTEIN SCIENCE (2005)
Regulation of glycogen metabolism in cultured human muscles by the glycogen phosphorylase inhibitor CP-91149
C Lerín et al.
BIOCHEMICAL JOURNAL (2004)
Uncoupling protein-2 deficiency promotes oxidant stress and delays liver regeneration in mice
M Horimoto et al.
HEPATOLOGY (2004)
Glucose 6-phosphate causes translocation of phosphorylase in hepatocytes and inactivates the enzyme synergistically with glucose
S Aiston et al.
BIOCHEMICAL JOURNAL (2004)
Obesity-related fatty liver is unchanged in mice deficient for mitochondrial uncoupling protein 2
G Baffy et al.
HEPATOLOGY (2002)
New efficient synthesis of β-glucosylamines of mono- and disaccharides with the use of ammonium carbamate
LM Likhosherstov et al.
DOKLADY CHEMISTRY (2002)
Hepatic glycogen synthesis is highly sensitive to phosphorylase activity -: Evidence from metabolic control analysis
S Aiston et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Disruption of the uncoupling protein-2 gene in mice reveals a role in immunity and reactive oxygen species production
D Arsenijevic et al.
NATURE GENETICS (2000)
Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage
T Nishikawa et al.
NATURE (2000)
Impaired glycogen synthesis in hepatocytes from Zucker fatty fa/fa rats:: the role of increased phosphorylase activity
S Aiston et al.
DIABETOLOGIA (2000)
Share Paper
